Getting High on Marijuana RTOs

There have been an overabundance of marijuana RTOs in the news lately. So much so that the SEC has even issued a warning regarding investing in these securities. Additionally, many of the shells (both manufactured and otherwise) are explicitly restricting investment in marijuana or cannabis-related businesses. We ourselves will not get into this arena — for numerous reasons.

Here are a few reasons marijuana-related reverse mergers represent a high risk for investors and the public at large.

Legality Outside the SEC

Some pot-centric businesses are not even legal. The SEC may issue the green light on a reverse merger with a business focused on Mary Jane, but that doesn’t mean the business has the green light from other laws. The issuance and dealings of securities is what the SEC is for. They don’t enforce other laws (e.g. The Controlled Substances Act) with which any cannabis company may be required to comply. And because the market penetration or acceptance in other states may be slower and less rapid than many marijuana companies hope, we may actually see a great deal of money move out of such investments in the short term only to come back later when the recreational use of pot becomes more widespread and across many more jurisdictions.

Typical Reverse Takeover Schemes & Microcap Issues

Two things trouble me about the rise of marijuana business operators — like cigarettes or alcohol, there could be questionable morality issues in general relating to such deals, combine that with the typical taints of reverse mergers and you’ve a very gasoline and fire combination.

For instance:

• Pump-n-dump schemes have already been reported with promotion outside what is considered clean and legal in the eyes of the SEC.
• The public float is low and insiders own large amounts of stock. The millions raised in such RTOs is typically going to a very small block of shareholders.
• Untested business models and roll-ups of businesses have large amounts of risks involved. That also means much more volatility in the price of the stock.
• If the company is on the Pinks or the OTC, it may be more difficult to get enough investment information to make a truly informed decision about the character of the business and its performance.
• In some cases, the stories of such companies are over-touted by their own internal Investor Relations and marketing. This is by design as it will typically lead to more investment and a higher valuation.

Risk/Return Tradeoff

No doubt this is a growth industry with nothing but upside potential. Consequently, there will be many who’ll be “flying very high” (pun intended) for their investment risk in pot companies. The CannLabs, Inc. deal saw substantial returns for the new owners who ended up with roughly 85% of the stock. In particular, the convertible preferred shareholders made out very well.

When the stock peaked a small original investment before the company went public would have been worth about 40x — not bad, but that reward comes with a substantial increase in risk. My personal feeling is that some shells are dirty enough with litigation and liability that sticking a cannabis business into the shell only makes things more tainted.

Big bets are being played in this space as a land grab ensues — the assumption being that now that Colorado and Washington have legalized, a more ubiquitous and widespread acceptance of the recreational use of pot will soon ensue.

If you’re going to drink the Kool Aid — or in this case — take a hit, be sure you know the risks before you get high on something that may already be overly inflated.

How Reverse Takeovers Work: A Brief Framework

For readers less familiar with the mechanics, a reverse merger (also called a Reverse Takeover, or RTO) is a transaction in which a private operating company merges into a publicly listed shell corporation. The result is that the private company’s owners gain a public listing without going through the traditional IPO process. The shell’s existing shareholders are typically diluted heavily, and the former private company’s management team takes operational control.

The appeal is speed and cost: bypassing a full registration and roadshow can get a company to public markets in weeks rather than months. The risk is that the transparency obligations of a newly public company are often underestimated, and shells frequently carry undisclosed liabilities, stale regulatory filings, and shareholder litigation from prior operations. Understanding how to focus on post-deal success in RTOs is critical for management teams navigating this process.

Why Cannabis RTOs Amplify Standard Reverse Merger Risks

Reverse mergers carry inherent structural risks regardless of the underlying business. The cannabis sector layered on additional complexity during the early legalization era for several interrelated reasons.

Federal-State Legal Conflict

Even in jurisdictions that had enacted state-level legalization, cannabis companies operated in a legally ambiguous environment at the federal level. This created banking challenges, tax complications under IRC Section 280E, and insurance gaps that most operating businesses never face. A shell with standard representations and warranties was frequently inadequate to address these exposures, leaving acquirers and investors with poorly understood legal risk buried in the cap table.

Valuation Without Comparable Data

Traditional M&A valuation relies on precedent transactions and public company trading multiples drawn from comparable businesses. In the early cannabis sector, comparable data was thin, inconsistent, and heavily influenced by speculative sentiment rather than fundamental operating performance. Advisors attempting to attract a high multiple for a cannabis business through an RTO were often working without reliable benchmarks, making it easier for promotional narratives to fill the analytical void.

Disclosure Quality on Pink Sheets and OTC Markets

Many cannabis RTOs traded on the OTC Bulletin Board or Pink Sheets, where disclosure requirements are substantially less rigorous than on national exchanges. Investors had limited access to audited financials, management track records, or verified business plans. This information asymmetry, combined with aggressive investor-relations campaigns, created conditions that the SEC explicitly flagged as pump-and-dump risk vectors.

What Legitimate Reverse Merger Candidates Look Like

Not all RTOs are problematic. The structure itself is a legitimate path to public markets when executed with clean shells, proper disclosures, and a credible operating business underneath. The distinguishing characteristics of a sound RTO candidate typically include audited financial statements prepared under GAAP, a management team with relevant public-company experience, a shell with no material undisclosed liabilities, and a business model with demonstrated (not projected) revenue. Reviewing how proprietary deal sourcing reduces M&A risk offers useful context on the diligence discipline that separates disciplined acquirers from opportunists.

For founders or investors evaluating any alternative public offering strategy — whether RTO, Reg A+, or traditional S-1 — understanding the full range of options is essential before committing to a path. If you are working through that decision, our team can help you prepare a transaction and evaluate which structure best fits your business and investor base.

Frequently Asked Questions

What is the difference between an RTO and a traditional IPO?

In a traditional IPO, a private company registers its shares directly with the SEC, hires underwriters, conducts a roadshow, and sells new shares to the public at a set offering price. In an RTO, the private company instead merges into an already-public shell, inheriting its public listing. RTOs are typically faster and cheaper but involve more opaque shells, limited institutional participation, and greater post-listing volatility.

Are all cannabis reverse mergers fraudulent or illegal?

No. The SEC’s warnings focused on elevated fraud risk and disclosure deficiencies, not on the legality of the structure itself. Some cannabis RTOs were executed transparently and generated legitimate returns. The SEC’s concern was that the combination of a speculative sector, thin disclosure requirements on OTC markets, and aggressive promotional activity created conditions ripe for manipulation — not that every deal was inherently dishonest.

How should investors approach high-risk RTO sectors?

Standard diligence applies: review audited financials, understand the shell’s history and any legacy liabilities, assess whether management has relevant public-company operating experience, and be skeptical of projections that lack supporting historical data. Sectors with federal-state legal conflicts or limited comparable transaction data require additional caution around valuation assumptions.